Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00879125 · ClinicalTrials.gov registry record
Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia
A clinical trial, sponsored by Vanderbilt University.
- Completed
- Registry status
- 219
- Enrollment target
NCT00879125: Completed study, sponsored by Vanderbilt University.
NCT00879125 is a clinical trial that has completed, run by Vanderbilt University. The registered enrollment target is 219 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00879125 has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- 219 participants
- Enrollment target
Study Summary
This is a retrospective review of patients who have undergone bariatric surgery at VUMC and who have type 2 Diabetes and/or dyslipidemia. The investigators have previously found that gastric bypass significantly improves diabetes 6-12 months after surgery. The investigators are interested in looking at the longer term results after surgery.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 1999-11 |
| Est. Completion | 2007-11 |
What the finished NCT00879125 record still lists
NCT00879125 is an observational study that tracks outcomes without assigning an intervention. The registered 219 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00879125 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00879125 about?
NCT00879125 is a clinical study titled "Effect of Gastric Bypass on Patients With Type 2 Diabetes and/or Dyslipidemia". This is a retrospective review of patients who have undergone bariatric surgery at VUMC and who have type 2 Diabetes and/or dyslipidemia. The investigators have previously found that gastric bypass significantly improves diabetes 6-12 months after surgery. The investigators are interested in looking...
What is the current status of trial NCT00879125?
This trial is currently completed. The enrollment target is 219 participants. The study started on 1999-11. Estimated completion is 2007-11.
Who is sponsoring clinical trial NCT00879125?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05196035 · 219 participants · Phase 3
A Study to Learn More About How Well the Study Treatment Finerenone Works, How Safe it is, How it Moves Into, Through, and Out of the Body, and the Effects it Has on the Body When Taken With an ACE Inhibitor or Angiotensin Receptor Blocker in Children With Chronic Kidney Disease and Proteinuria
- NCT05608434 · 219 participants · Phase 1
Development of Virtual Reality-based Interventions to Strengthen Cognitive Skillsets Related to Attention Deficit Hyperactivity Disorder (ADHD): A Pilot Phase I and Randomized Controlled Phase II Trial
- NCT05773144 · 219 participants · NA
Adaptive Randomization of Aerobic Exercise During Chemotherapy in Colon Cancer
- NCT05907980 · 219 participants · Phase 1
A Phase I Study of ROSE12 Alone and in Combination With Other Anti-tumor Agents in Patients With Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia